An India-based multinational pharmaceutical manufacturer has agreed to pay $12.9 million to settle claims it reported inflated prices to the Texas Medicaid program, the Texas attorney general said June 8.
Dr. Reddy's Laboratories alleged inflated price-reporting began in October 2003, according to the settlement agreement. The company denies wrongdoing.